We’ve recently updated our valuation analysis.

SILK Laser Australia Valuation

Is SLA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score

6/6

Valuation Score 6/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SLA?

Other financial metrics that can be useful for relative valuation.

SLA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.6x
Enterprise Value/EBITDA8.5x
PEG Ratio0.8x

Price to Earnings Ratio vs Peers

How does SLA's PE Ratio compare to its peers?

The above table shows the PE ratio for SLA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average26.2x
AHX Apiam Animal Health
26.1x17.4%AU$122.8m
CAJ Capitol Health
31.7x23.2%AU$340.1m
ACL Australian Clinical Labs
3.8x-51.4%AU$674.7m
IDX Integral Diagnostics
43.2x22.9%AU$643.0m
SLA SILK Laser Australia
16.7x21.0%AU$106.8m

Price-To-Earnings vs Peers: SLA is good value based on its Price-To-Earnings Ratio (16.7x) compared to the peer average (26.2x).


Price to Earnings Ratio vs Industry

How does SLA's PE Ratio compare vs other companies in the Global Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a5.5%
n/an/an/a

Price-To-Earnings vs Industry: SLA is good value based on its Price-To-Earnings Ratio (16.7x) compared to the Global Healthcare industry average (18.8x)


Price to Earnings Ratio vs Fair Ratio

What is SLA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SLA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.7x
Fair PE Ratio23x

Price-To-Earnings vs Fair Ratio: SLA is good value based on its Price-To-Earnings Ratio (16.7x) compared to the estimated Fair Price-To-Earnings Ratio (23x).


Share Price vs Fair Value

What is the Fair Price of SLA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SLA (A$2.01) is trading below our estimate of fair value (A$3.85)

Significantly Below Fair Value: SLA is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SLA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$2.01
AU$3.41
+69.8%
9.5%AU$3.80AU$2.96n/a4
Nov ’23AU$2.15
AU$3.41
+58.7%
9.5%AU$3.80AU$2.96n/a4
Oct ’23AU$2.05
AU$3.41
+66.5%
9.5%AU$3.80AU$2.96n/a4
Sep ’23AU$2.61
AU$3.41
+30.7%
9.5%AU$3.80AU$2.96n/a4
Aug ’23AU$2.55
AU$3.23
+26.6%
12.0%AU$3.74AU$2.80n/a3
Jul ’23AU$1.91
AU$3.89
+104.2%
26.2%AU$5.25AU$2.80n/a3
Jun ’23AU$2.65
AU$4.44
+67.4%
18.4%AU$5.25AU$3.62n/a2
May ’23AU$2.82
AU$4.72
+67.5%
16.5%AU$5.30AU$3.62n/a3
Apr ’23AU$3.30
AU$5.51
+66.9%
6.0%AU$5.97AU$5.25n/a3
Mar ’23AU$3.53
AU$5.51
+56.0%
6.0%AU$5.97AU$5.25n/a3
Feb ’23AU$3.90
AU$5.57
+42.9%
9.5%AU$6.32AU$5.15n/a3
Jan ’23AU$4.26
AU$5.57
+30.8%
9.5%AU$6.32AU$5.15n/a3
Dec ’22AU$4.30
AU$5.32
+23.8%
14.1%AU$6.32AU$4.50AU$2.013
Nov ’22AU$4.40
AU$5.32
+21.0%
14.1%AU$6.32AU$4.50AU$2.153
Oct ’22AU$4.67
AU$4.68
+0.1%
3.7%AU$4.85AU$4.50AU$2.052
Sep ’22AU$3.94
AU$4.68
+18.7%
3.7%AU$4.85AU$4.50AU$2.612
Aug ’22AU$3.85
AU$4.80
+24.6%
5.4%AU$5.06AU$4.54AU$2.552
Jul ’22AU$4.39
AU$4.80
+9.3%
5.4%AU$5.06AU$4.54AU$1.912
Jun ’22AU$4.00
AU$4.76
+18.9%
6.4%AU$5.06AU$4.45AU$2.652
May ’22AU$4.42
AU$4.76
+7.6%
6.4%AU$5.06AU$4.45AU$2.822
Apr ’22AU$4.64
AU$4.76
+2.5%
6.4%AU$5.06AU$4.45AU$3.302
Mar ’22AU$4.74
AU$4.53
-4.4%
1.8%AU$4.61AU$4.45AU$3.532
Feb ’22AU$3.98
AU$4.61
+15.8%
0%AU$4.61AU$4.61AU$3.901

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies